Molecular characterization of colicinogenic E.coli inhibitory to E.coli O157:H7 and E.coli O26:H11

Paper Details

Research Paper 01/09/2019
Views (237) Download (11)

Molecular characterization of colicinogenic E.coli inhibitory to E.coli O157:H7 and E.coli O26:H11

Hira Mushtaq, Jehan Bakht, Ibrar Khan, Soniya Amir, Bashir Ahmad
Int. J. Biosci.15( 3), 379-391, September 2019.
Certificate: IJB 2019 [Generate Certificate]


Bacteriocinogenic microbial species are considered as an emerging alternative to antibiotics due to their enhanced prophylaxis against invading pathogens. Commensal E.coli, from human, cattle and sheep, was examined for its ability to competitively exclude closely related species in-vitro and the antimicrobials released were analyzed. E.coli isolates (n=513) screened for anti–E.coli O157:H7 and O26:H11 activity in-vitro and the release of colicins. Among all, 9.3% colicinogenic E.coli inhibited the growth of these pathogen species. Colicin gene detection showed that col E6 (77%) andIb (64%) were most frequently occurring colicins in inhibitory E.coli followed by colE7 (52%), E4 (58%),Ia (27%), J (37%), M (27%), S4(18%) and E3 (18%). Other colicins (col A, D, E1, E2, E5, E8, E9 and col 10) were less frequently detected whereas col B, K and 5 were not detected in any E.coli isolates. Phylogeney of these colicinogenic E.coli classified isolates as 47% B2, 16% B1, 16% D1, 10% A1 and 8.3% A0 E.coli. Virulence gene detection and 16SrDNA sequencing confirmed15 non-pathogenic E.coli strains which also showed sensitivity to commonly used antibiotics and were lacking siderophore activity.The study concludes that the potential role of E.coli in human and animalgut is to competitively exclude invading pathogens. Thus, non-virulent colicininogenicE.coli can be suggested for further detailed studies, both in-vitro and in-vivo, to be used as probiotics.


Bradley DE, Howard SP, Lior H. 1990. Colicinogeny of O157:H7 enterohemorrhagic Escherichia coli and the shielding of colicin and phage receptors by their O-antigenic side chains. Canadian  journal of Microbiology 37, 7–104.

Brashears MM, D Jaroni, Trimble J. 2003. Isolation, selection and characterization of lactic acid bacteria for a competitive exclusion product to reduce shedding of Escherichia coli O157:H7 in cattle. Journal of Food Protection 66, 355–363.

Camila C, Mathias M P, Nancy C S, Elayse M H, Maria IZ S, Tânia AT, Luiz A, Laura M. 2010.Escherichia coli phylogenetic group determination and its application in the identification of the major animal source of fecal contamination. Biomedcentral Microbiology 10, 161.

Cascales E, Buchanan SK, Duche D, Kleanthous C, Lloubes R, Postle K, Riley M, Slatin S, Cavard D. 2017. Colicin biology. Microbiology and Molecular Biology Review 71, 158–229.

Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and Simple Determination of the Escherichia coli Phylogenetic Group. Applied Environmental Microbiology 66(10), 4555–4558.

Collado MC, Isolauri E, Salminen S, Sanz Y. 2009. The impact of probiotic on gut health. Current Drug Metabolism 10, 68 –78.

DebRoy C, Jayarao B. 2002.  Competitive Exclusion of E.coli O157:H7 using non-pathogenic bacteriocins producing Escherichia coli strains. The Pennsylvania State University, University Park, PA 16802.

DebRoy C, Maddox CW. 2001. Identification of virulence attributes of gastrointestinal Escherichia coli isolates of veterinary significance. Animal Health Research Review 1,129–140.

DebRoy C, Roberts E, Kundrat J, Davis MA, Briggs CE, Fratamico PM. 2004. Detection of Escherichia coli serogroups O26 and O113 by PCR amplification of the wzx and wzy genes. Applied Environmental Microbiology 70, 1830–1832.

Gerry P. Schamberger, Francisco DG. 2004. Characterization of Colicinogenic Escherichia coli Strains Inhibitory to Enterohemorrhagic Escherichia coli. Journal of Food Protection 67(3), 486-492.

Hahn-Löbmann S, Stephan A, Schulz S, Schneider A, Shaverskyi A, Daniel  T, Giritch T, Gleba Y. 2019.. Colicins and Salmocins – new classes of plant-made non-antibiotic food antibacterials. Frontiers in Plant Sciences 10, 437.

Ingle DJ, Levine MM, Kotloff KL, Holt KE, Robins-Browne RM. 2018. Dynamics of antimicrobial resistance in intestinal Escherichia coli from children in community settings in South Asia and sub-Saharan Africa. Natures Microbiology 3(9), 1063-1073.

James J, Biemer MD. 1973. Antimicrobial susceptibility testing by the Kirby-Bauer disc diffusion method. Annuals of clinical laboratory sciences 3(2), 135-140.

Kohoutová D, Šmajs D, Moravkova P, Cyrany J, Moravkova M, Forstlova M, Cihak M, Rejchrt S, Bures J. 2014. Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia. Biomedcentral Infectious Diseases 14, 733-966.

Micenková K, Barbora S, Juraj B, Lenka M, Simona L, Martin V, Alena S, Iadana W, Smajs D. 2014. Bacteriocin- encoding genes and ExPEC virulence determinants are associated in human fecal Escherichia coli strains. Biomedcentral Microbiology 14, 109.

Micenková L, Juraj B, Martin V, Ševčíková A, Šmajs D. 2016. Human extraintestinal pathogenic Escherichia coli strains differ in prevalence of virulence factors, phylogroups, and bacteriocin determinantal. Biomedcentral Microbiology 16, 218.

Murinda SE, Roberts RF, Wilson RA. 1996. Evaluation of colicins for inhibitory activity against diarrheagenic Escherichia coli strains, including serotype O157:H7. Applied Environmental Microbiology 62, 3196–3202. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Wayne, Penn 2000.

Nedialkova LP, Denzler R, Koeppel MB, Diehl M, Ring D, Wille T. 2014. Inflammation fuels colicin Ib-dependent competition of Salmonella serovar typhimurium and E.coli in Enterobacterial blooms. PLoS Pathogen 10, e1003844.

Nowrouzian FL, Ostblom AE, Wold WE, Adlerberth. 2009. Phylogenetic group B2 Escherichia coli strains from the bowel microbiota of Pakistani infants carry few virulence genes and lack of capacity for long-term persistence. Clinical Microbiology Infections 15, 466–472.

Rolf R, Walter P, Hammes FD, Bello R, Prager A, FruthKlaus HA, Rakin M, Starcic-Erjavec Peter HW. 2009. Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli. Federation of European Microbiological Society Microbiology Letters 290(1), 62–69.

Schamberger GP, Diez-Gonzalez F. 2002. Selection of recently isolated colicinogenic Escherichia coli strains inhibitory against E.coli O157:H7. Journal of Food Protection 65, 1381–1387.

Schamberger GP, Diez-Gonzalez. 2005.  Assessment of resistance to colicinogenic Escherichia coli by E.coli O157:H7 strains. Journal of Applied Microbiology 98(1), 245-52.

Schulz S, Stephan A, Hahn S, Bortesi L, Jarczowski F, Bettmann U. 2015.Broad and efficient control of major foodborne pathogenic strains of Escherichia coli by mixtures of plant-produced colicins. Proceedings of the National Academy of Sciences 112, 5454–5460.

Schwyn B, Neilands JB. 1987. Universal chemical assay for the detection and determination of siderophores. Analytical Biochemistry 160, 47–56.

Simujide Huasai, Aorigele C, Chun-jie W, Yu L, Tongrige B. 2012. Occurrence and characteristics of virulence genes of Escherichia coli strains isolated from healthy dairy cows in Inner Mongolia, China. Brazilian Journal of Microbiology 43(2), 528-534.

Šmajs D, Lenka M, Jan Š, Martin V, Alena Š, Zuzana V, Vladana W. 2010. Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor. BMC Microbiology 10, 288.

Smarda J, Obdrzálek V.2001. Incidence of colicinogenic strains among human Escherichia coli. Journal of Basic Microbiology 41(6), 367-74.

Suresh A, Manikkam R, Gopal S, Nainangu P, Sivaraj A, Jerrine J. 2014.Isolation of colicinogenic E.coli, optimization of colicin production and transformation of colicin production and transformation of Col plasmid. Journal of Applied Pharmaceutical Sciences 4, 47-49.

Tharmaraj N, Shah NP. 2009. Antimicrobial effects of probiotics against selected pathogenic and spoilage bacteria in cheese-based dips. International Food Review 16, 261-276.

Toshima H, Yoshimura A, Arikawa K, Hidaka A. 2008. Enhancement of Shiga Toxin Production in Enterohemorrhagic Escherichia coli Serotype O157:H7 by DNase Colicin. Applied and Environmental Microbiology 73(23), 7582-8.

Willyard C. 2017. The drug-resistant bacteria that pose the greatest health threats. Nature 543(7643), 15.

Zhao T, Doyle MP, Harmon BG, Brown CA, Mueller P, Parks AP. 1998.  Reduction of carriage of entero- hemorrhagic Escherichia coli O157:H7 in cattle by inoculation with probiotic bacteria. Journal of Clinical Microbiology 36, 641–647.